OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2021
(6)
2022
(5)
2024
(2)
2025
(1)
2023
(1)
2020
(1)
2019
(1)
2017
(1)
2015
(1)
2014
(1)
2013
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
The role of IL-23 and the IL-23/T
H
17 immune axis in the pathogenesis and treatment of psoriasis.
Not available
S-EPMC5697699
|
biostudies-literature
Cite
SARS-CoV-2 infection inducing severe flare up of Deficiency of Interleukin Thirty-six (IL-36) Receptor Antagonist (DITRA) resulting from a mutation invalidating the activating cleavage site of the IL-36 receptor antagonist.
Not available
S-EPMC8235915
|
biostudies-literature
Cite
Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares.
Not available
S-EPMC10233699
|
biostudies-literature
Cite
Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials.
Not available
S-EPMC7379291
|
biostudies-literature
Cite
Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
Not available
S-EPMC8011793
|
biostudies-literature
Cite
Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians.
Not available
S-EPMC4359024
|
biostudies-literature
Cite
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab.
Not available
S-EPMC7489429
|
biostudies-literature
Cite
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.
Not available
S-EPMC11393270
|
biostudies-literature
Cite
Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.
Not available
S-EPMC9298814
|
biostudies-literature
Cite
Frequence des rechutes et signes cutanes persistants apres un premier episode de pseudo engelure durant la pandemie COVID-19
Not available
S-EPMC8603665
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets